FRR Shares (Makes you Realise)

Equity

Home/ Are You A Trader/ Market Info/ Company Profile/ Smart Quotes

COMPANY PROFILE

KWALITY PHARMACEUTICALS LTD.

NSE : KPLBSE : 539997ISIN CODE : INE552U01010Industry : Pharmaceuticals & DrugsHouse : Private

BSE3310.2544.75 (+1.37 %)

PREV CLOSE (Rs.) 3265.50

OPEN PRICE (Rs.) 3292.85

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1704

TODAY'S LOW / HIGH (Rs.)3263.80 3326.75

52 WK LOW / HIGH (Rs.)828.8 3725.45

NSE3314.3047.2 (+1.44 %)

PREV CLOSE( Rs. ) 3267.10

OPEN PRICE (Rs.) 3276.60

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 18523

TODAY'S LOW / HIGH(Rs.) 3257.70 3338.40

52 WK LOW / HIGH (Rs.)1561 3744

More From Company Profile

Smart Quotes

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Trade Value (Rs. in Lacs)

56.19

Dividend Yield(%)

0.00

TTM EPS (Rs.)

78.10

P/E Ratio

42.39

Book Value (Rs.)

345.21

Face Value (Rs.)

MCap (Rs. in Mn)

34347.81

Price/Earning (TTM)

33.99

Price/Sales (TTM)

6.20

Price/Book (MRQ)

9.59

PAT Margin (%)

13.39

ROCE (%)

23.90

Incorporation Year : 04-05 1983

Management Info :

- Chairman Ramesh Kumar - Managing Director

Registered Office :

Address : 6th Mile Stone,Village Nagkalan,Majitha Road,
Amritsar,
Punjab-143601

Phone : 08558820862 / 63 / 9915743720

Email : export@kwalitypharma.com / ramesh@kwalitypharma.com

Website : www.kwalitypharma.com

Registrars Details :

Bigshare Services Pvt Ltd

Office No S6-2, 6th Floor, Pinnacle Business Park,Next to Ahura Centre, Mahakali Caves Road,Andheri (E),Mumbai

Listing : BSE, NSE

NEWS

13Jul Kwality Pharmaceuticals informs about
Kwality Pharmaceuticals has enclosed confirmation certificate issued in..

10Mar Kwality Pharmaceuticals informs about
Kwality Pharmaceuticals has informed that it enclosed Disclosure under R..

05Mar Kwality Pharmaceuticals informs about
Pursuant to Regulation 30 of the Securities and Exchange Board of India..

Financials

	QTR Jun 26	ANNUAL 26
Net Profit	256.26	673.49
Gross Profit	339.91	894.95
Operating Profit	416.44	1210.88
Net Sales	1623.52	5030.59

Rs. in Millions

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Divi's Laboratories (BSE)

9269.00 (2.42%)

M.Cap (Rs. in Cr)246062.83

Glenmark Pharma. (BSE)

2517.40 (2.50%)

M.Cap (Rs. in Cr)71047.24

Sanofi Cons. Health (BSE)

4213.65 (1.37%)

M.Cap (Rs. in Cr)9704.30

Haleos Labs (BSE)

1542.00 (2.97%)

M.Cap (Rs. in Cr)466.19

Shareholding Pattern

	PROMOTERS	54.86%
	NON-INSTITUTION	41.44%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holding

Scheme Name

Hold(%)

No Data Found

Attention Investors

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month, Issued in the interest of Investors.

Risk Disclosure on Derivatives | Smart ODR | Mandatory Display | KYC Validation Links

BSE / NSE SEBI Registration No. INZ000279232, Depository Participant SEBI Registration No. – IN DP CDSL 132-2015

Mutual funds - ARN No. 81648 , Investment Adviser SEBI Registration No. : INA000008668.

close X

Download Client Registration Documents

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language :

Assamese Bengali Gujarati Hindi Kanada

Kashmiri Konkani Malyalam Marathi Oriya

Punjabi Sindhi Tamil Telegu Urdu

NOTE : " This document is a translated version of the client registration documents in English and is being provided in vernacular language to facilitate better understanding by the investors. In case of any ambiguity, the contents of the English version would prevail. "

CLOSE X

Risk Disclosures On Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22